Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2016

01-05-2016 | Original Article

Modeling correlates of low bone mineral density in patients with phenylalanine hydroxylase deficiency

Authors: Kathryn E. Coakley, Teresa D. Douglas, Michael Goodman, Usha Ramakrishnan, Steven F. Dobrowolski, Rani H. Singh

Published in: Journal of Inherited Metabolic Disease | Issue 3/2016

Login to get access

Abstract

Phenylalanine hydroxylase (PAH) deficiency is an inherited metabolic disorder requiring life-long restriction of dietary protein and phenylalanine-free medical food. Low bone mineral density (BMD) is reported, but factors associated with BMD Z-score (standard deviations from normal) are unknown. We examined associations between clinical and dietary parameters and total BMD Z-score in PAH deficiency patients, and developed models to predict Z-score. Data collected from patients >4 years of age (n = 88; mean age = 18.8 y; 61 % female) included demographic, clinical, laboratory, and dietary intakes. Adjusted Spearman’s correlation coefficients were calculated between parameters and TBMD Z-score, measured by dual energy x-ray absorptiometry (DXA). Parameters approaching significance (p-value < 0.10) were candidate predictors for four linear regression models predicting TBMD Z-score. To validate, model-predicted Z-scores were compared to DXA Z-scores. Mean TBMD Z-score was −0.326; 18 (20.4 %) had Z-score < −1. Z-scores were positively correlated with dietary vitamin D, calcium, and medical food intake and compliance with prescription, and negatively with dietary carbohydrate, sugar, caffeine intake, glycemic load, and prescribed medical food (grams protein/day; p-value < 0.05). The best model included medical food compliance, medical food intake, caffeine intake, and bone-specific alkaline phosphatase (r-square = 0.364). This model predicted Z-score category [normal or low (<−1)] with sensitivity = 66.7 %, likelihood ratio = 14.7, and AUC = 0.83 compared to DXA Z-score. No subjects had low BMD for chronological age (Z-score ≤ −2). Compliance with medical food prescription was the strongest predictor of TBMD Z-score. One model, if validated in a separate sample of patients with more cases of low BMD, showed potential to estimate TBMD Z-score using routine clinical patient parameters.
Appendix
Available only for authorised users
Literature
go back to reference Bellazzi R, Zupan B (2008) Predictive data mining in clinical medicine: current issues and guidelines. Int J Med Inform 77(2):81–97 Bellazzi R, Zupan B (2008) Predictive data mining in clinical medicine: current issues and guidelines. Int J Med Inform 77(2):81–97
go back to reference Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Reginster JY, Gangji V, M. Members of Advisory Board on Bone (2009) Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. Int J Clin Pract 63(1):19–26 Bergmann P, Body JJ, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Reginster JY, Gangji V, M. Members of Advisory Board on Bone (2009) Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. Int J Clin Pract 63(1):19–26
go back to reference Bhupathiraju SN, Tobias DK, Malik VS, Pan A, Hruby A, Manson JE, Willett WC, Hu FB (2014) Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr 100(1):218–232 Bhupathiraju SN, Tobias DK, Malik VS, Pan A, Hruby A, Manson JE, Willett WC, Hu FB (2014) Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr 100(1):218–232
go back to reference Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, Bodamer OA, Brosco JP, Brown CS, Burlina AB, Burton BK, Chang CS, Coates PM, Cunningham AC, Dobrowolski SF, Ferguson JH, Franklin TD, Frazier DM, Grange DK, Greene CL, Groft SC, Harding CO, Howell RR, Huntington KL, Hyatt-Knorr HD, Jevaji IP, Levy HL, Lichter-Konecki U, Lindegren ML, Lloyd-Puryear MA, Matalon K, MacDonald A, McPheeters ML, Mitchell JJ, Mofidi S, Moseley KD, Mueller CM, Mulberg AE, Nerurkar LS, Ogata BN, Pariser AR, Prasad S, Pridjian G, Rasmussen SA, Reddy UM, Rohr FJ, Singh RH, Sirrs SM, Stremer SE, Tagle DA, Thompson SM, Urv TK, Utz JR, van Spronsen F, Vockley J, Waisbren SE, Weglicki LS, White DA, Whitley CB, Wilfond BS, Yannicelli S, Young JM (2014) Phenylketonuria scientific review conference: state of the science and future research needs. Mol Genet Metab 112(2):87–122 Camp KM, Parisi MA, Acosta PB, Berry GT, Bilder DA, Blau N, Bodamer OA, Brosco JP, Brown CS, Burlina AB, Burton BK, Chang CS, Coates PM, Cunningham AC, Dobrowolski SF, Ferguson JH, Franklin TD, Frazier DM, Grange DK, Greene CL, Groft SC, Harding CO, Howell RR, Huntington KL, Hyatt-Knorr HD, Jevaji IP, Levy HL, Lichter-Konecki U, Lindegren ML, Lloyd-Puryear MA, Matalon K, MacDonald A, McPheeters ML, Mitchell JJ, Mofidi S, Moseley KD, Mueller CM, Mulberg AE, Nerurkar LS, Ogata BN, Pariser AR, Prasad S, Pridjian G, Rasmussen SA, Reddy UM, Rohr FJ, Singh RH, Sirrs SM, Stremer SE, Tagle DA, Thompson SM, Urv TK, Utz JR, van Spronsen F, Vockley J, Waisbren SE, Weglicki LS, White DA, Whitley CB, Wilfond BS, Yannicelli S, Young JM (2014) Phenylketonuria scientific review conference: state of the science and future research needs. Mol Genet Metab 112(2):87–122
go back to reference Cederbaum S (2002) Phenylketonuria: An update. Curr Opin Pediatr 14(6):702–706 Cederbaum S (2002) Phenylketonuria: An update. Curr Opin Pediatr 14(6):702–706
go back to reference de Groot MJ, Hoeksma M, van Rijn M, Slart RH, van Spronsen FJ (2012) Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients. Mol Genet Metab 105(4):566–570 de Groot MJ, Hoeksma M, van Rijn M, Slart RH, van Spronsen FJ (2012) Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients. Mol Genet Metab 105(4):566–570
go back to reference Demirdas S, Coakley KE, Bisschop PH, Hollak CE, Bosch AM, Singh RH (2015) Bone health in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis 10(1):17 Demirdas S, Coakley KE, Bisschop PH, Hollak CE, Bosch AM, Singh RH (2015) Bone health in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis 10(1):17
go back to reference Demirkol M, Gizewska M, Giovannini M, Walter J (2011) Follow up of phenylketonuria patients. Mol Genet Metab 104(Suppl):S31–S39 Demirkol M, Gizewska M, Giovannini M, Walter J (2011) Follow up of phenylketonuria patients. Mol Genet Metab 104(Suppl):S31–S39
go back to reference Di Daniele N, Carbonelli MG, Candeloro N, Iacopino L, De Lorenzo A, Andreoli A (2004) Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial. Pharmacol Res 50(6):637–641 Di Daniele N, Carbonelli MG, Candeloro N, Iacopino L, De Lorenzo A, Andreoli A (2004) Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial. Pharmacol Res 50(6):637–641
go back to reference Efendic S, Cerasi E, Luft R (1971) Role of glucose in arginine-induced insulin release in man. Metabolism 20(6):568–579 Efendic S, Cerasi E, Luft R (1971) Role of glucose in arginine-induced insulin release in man. Metabolism 20(6):568–579
go back to reference El Maghraoui A, Roux C (2008) DXA scanning in clinical practice. QJM 101(8):605–617 El Maghraoui A, Roux C (2008) DXA scanning in clinical practice. QJM 101(8):605–617
go back to reference Frank MP, Powers RW (2007) Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids. J Chromatogr B Analyt Technol Biomed Life Sci 852(1–2):646–649 Frank MP, Powers RW (2007) Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids. J Chromatogr B Analyt Technol Biomed Life Sci 852(1–2):646–649
go back to reference Garcia-Hernandez A, Arzate H, Gil-Chavarria I, Rojo R, Moreno-Fierros L (2012) High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone 50(1):276–288 Garcia-Hernandez A, Arzate H, Gil-Chavarria I, Rojo R, Moreno-Fierros L (2012) High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone 50(1):276–288
go back to reference Goran MI, Driscoll P, Johnson R, Nagy TR, Hunter G (1996) Cross-calibration of body-composition techniques against dual-energy X-ray absorptiometry in young children. Am J Clin Nutr 63(3):299–305 Goran MI, Driscoll P, Johnson R, Nagy TR, Hunter G (1996) Cross-calibration of body-composition techniques against dual-energy X-ray absorptiometry in young children. Am J Clin Nutr 63(3):299–305
go back to reference Harding CO (2010) New era in treatment for phenylketonuria: pharmacologic therapy with sapropterin dihydrochloride. Biologics 4:231–236 Harding CO (2010) New era in treatment for phenylketonuria: pharmacologic therapy with sapropterin dihydrochloride. Biologics 4:231–236
go back to reference Harnack L, Stevens M, Van Heel N, Schakel S, Dwyer JT, Himes J (2008) A computer-based approach for assessing dietary supplement use in conjunction with dietary recalls. J Food Compost Anal 21(Suppliment 1):S78–S82 Harnack L, Stevens M, Van Heel N, Schakel S, Dwyer JT, Himes J (2008) A computer-based approach for assessing dietary supplement use in conjunction with dietary recalls. J Food Compost Anal 21(Suppliment 1):S78–S82
go back to reference Hernandez-Avila M, Stampfer MJ, Ravnikar VA, Willett WC, Schiff I, Francis M, Longcope C, McKinlay SM, Longscope C (1993) Caffeine and other predictors of bone density among pre- and perimenopausal women. Epidemiology 4(2):128–134 Hernandez-Avila M, Stampfer MJ, Ravnikar VA, Willett WC, Schiff I, Francis M, Longcope C, McKinlay SM, Longscope C (1993) Caffeine and other predictors of bone density among pre- and perimenopausal women. Epidemiology 4(2):128–134
go back to reference Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467–475 Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467–475
go back to reference Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone 44(5):734–743 Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone 44(5):734–743
go back to reference Koura HM, Abdallah Ismail N, Kamel AF, Ahmed AM, Saad-Hussein A, Effat LK (2011) A long-term study of bone mineral density in patients with phenylketonuria under diet therapy. Arch Med Sci 7(3):493–500 Koura HM, Abdallah Ismail N, Kamel AF, Ahmed AM, Saad-Hussein A, Effat LK (2011) A long-term study of bone mineral density in patients with phenylketonuria under diet therapy. Arch Med Sci 7(3):493–500
go back to reference Leib ES, Lewiecki EM, Binkley N, Hamdy RC (2004) Official positions of the international society for clinical densitometry. South Med J 97(1):107–110 Leib ES, Lewiecki EM, Binkley N, Hamdy RC (2004) Official positions of the international society for clinical densitometry. South Med J 97(1):107–110
go back to reference Lloyd T, Rollings NJ, Kieselhorst K, Eggli DF, Mauger E (1998) Dietary caffeine intake is not correlated with adolescent bone gain. J Am Coll Nutr 17(5):454–457CrossRefPubMed Lloyd T, Rollings NJ, Kieselhorst K, Eggli DF, Mauger E (1998) Dietary caffeine intake is not correlated with adolescent bone gain. J Am Coll Nutr 17(5):454–457CrossRefPubMed
go back to reference Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259 Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259
go back to reference Miras A, Boveda MD, Leis MR, Mera A, Aldamiz-Echevarria L, Fernandez-Lorenzo JR, Fraga JM, Couce ML (2013) Risk factors for developing mineral bone disease in phenylketonuric patients. Mol Genet Metab 108(3):149–154 Miras A, Boveda MD, Leis MR, Mera A, Aldamiz-Echevarria L, Fernandez-Lorenzo JR, Fraga JM, Couce ML (2013) Risk factors for developing mineral bone disease in phenylketonuric patients. Mol Genet Metab 108(3):149–154
go back to reference Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, Efrati O (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30(2):202–208 Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, Efrati O (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30(2):202–208
go back to reference Newsholme P, Bender K, Kiely A, Brennan L (2007) Amino acid metabolism, insulin secretion and diabetes. Biochem Soc Trans 35(Pt 5):1180–1186 Newsholme P, Bender K, Kiely A, Brennan L (2007) Amino acid metabolism, insulin secretion and diabetes. Biochem Soc Trans 35(Pt 5):1180–1186
go back to reference Perez-Duenas B, Cambra FJ, Vilaseca MA, Lambruschini N, Campistol J, Camacho JA (2002) New approach to osteopenia in phenylketonuric patients. Acta Paediatr 91(8):899–904 Perez-Duenas B, Cambra FJ, Vilaseca MA, Lambruschini N, Campistol J, Camacho JA (2002) New approach to osteopenia in phenylketonuric patients. Acta Paediatr 91(8):899–904
go back to reference Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield SB (1998) Body mass index as a measure of adiposity among children and adolescents: a validation study. J Pediatr 132(2):204–210 Pietrobelli A, Faith MS, Allison DB, Gallagher D, Chiumello G, Heymsfield SB (1998) Body mass index as a measure of adiposity among children and adolescents: a validation study. J Pediatr 132(2):204–210
go back to reference Przyrembel H, Bremer HJ (2000) Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S129–S135 Przyrembel H, Bremer HJ (2000) Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S129–S135
go back to reference Quirk ME, Dobrowolski SF, Nelson BE, Coffee B, Singh RH (2012) Utility of phenylalanine hydroxylase genotype for tetrahydrobiopterin responsiveness classification in patients with phenylketonuria. Mol Genet Metab 107(1–2):31–36 Quirk ME, Dobrowolski SF, Nelson BE, Coffee B, Singh RH (2012) Utility of phenylalanine hydroxylase genotype for tetrahydrobiopterin responsiveness classification in patients with phenylketonuria. Mol Genet Metab 107(1–2):31–36
go back to reference Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL (2001) Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 74(5):694–700 Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL (2001) Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 74(5):694–700
go back to reference Rocha JC, van Spronsen FJ, Almeida MF, Soares G, Quelhas D, Ramos E, Guimaraes JT, Borges N (2012) Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome. Mol Genet Metab 107(4):659–663 Rocha JC, van Spronsen FJ, Almeida MF, Soares G, Quelhas D, Ramos E, Guimaraes JT, Borges N (2012) Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome. Mol Genet Metab 107(4):659–663
go back to reference Singh RH, Rohr F, Frazier D, Cunningham A, Mofidi S, Ogata B, Splett PL, Moseley K, Huntington K, Acosta PB, Vockley J, Van Calcar SC (2014) Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet Med 16(2):121–131 Singh RH, Rohr F, Frazier D, Cunningham A, Mofidi S, Ogata B, Splett PL, Moseley K, Huntington K, Acosta PB, Vockley J, Van Calcar SC (2014) Recommendations for the nutrition management of phenylalanine hydroxylase deficiency. Genet Med 16(2):121–131
go back to reference Stewart RM, Hemli S, Kolodny EH, Miller AL, Pallotta JA (1980) Carbohydrate metabolism in phenylketonuria. Pediatr Res 14(7):849–853 Stewart RM, Hemli S, Kolodny EH, Miller AL, Pallotta JA (1980) Carbohydrate metabolism in phenylketonuria. Pediatr Res 14(7):849–853
go back to reference van Kuijk C (2010) Pediatric bone densitometry. Radiol Clin North Am 48(3):623–627 van Kuijk C (2010) Pediatric bone densitometry. Radiol Clin North Am 48(3):623–627
go back to reference Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA, G. American College of Medical and C. Genomics Therapeutics (2014) Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 16(2):188–200 Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA, G. American College of Medical and C. Genomics Therapeutics (2014) Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 16(2):188–200
go back to reference Williams RA, Mamotte CD, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29(1):31–41 Williams RA, Mamotte CD, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29(1):31–41
go back to reference Winzenberg T, Jones G (2011) Dual energy X-ray absorptiometry. Aust Fam Physician 40(1–2):43–44 Winzenberg T, Jones G (2011) Dual energy X-ray absorptiometry. Aust Fam Physician 40(1–2):43–44
go back to reference Zeman J, Bayer M, Stepan J (1999) Bone mineral density in patients with phenylketonuria. Acta Paediatr 88(12):1348–1351 Zeman J, Bayer M, Stepan J (1999) Bone mineral density in patients with phenylketonuria. Acta Paediatr 88(12):1348–1351
Metadata
Title
Modeling correlates of low bone mineral density in patients with phenylalanine hydroxylase deficiency
Authors
Kathryn E. Coakley
Teresa D. Douglas
Michael Goodman
Usha Ramakrishnan
Steven F. Dobrowolski
Rani H. Singh
Publication date
01-05-2016
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2016
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9910-0

Other articles of this Issue 3/2016

Journal of Inherited Metabolic Disease 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.